1. Stocks
  2. Piramal Pharma Ltd.
  3. Swot
swot-logo

Piramal Pharma Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Piramal Pharma Ltd. has 15 Strengths, 11 Weaknesses, 5 Opportunities and 1 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Price crossing above SMA20 today, and greater than SMA5

Expensive Performers (DVM)

Annual Profit Growth higher than Sector Profit Growth

Relative Outperformance versus Industry over 1 Week

Effectively using its capital to generate profit - RoCE improving in last 2 years

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

Stock with Low PE (PE < = 10)

High Volume, High Gain

Top Gainers

High Volume, High Gain

Volume Shockers

PEG greater than Industry PEG

Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Declining profits every quarter for the past 2 quarters

Declining Net Cash Flow : Companies not able to generate net cash

Major fall in TTM Net Profit

Fall in Quarterly Revenue and Net Profit (YoY)

Near 52 Week Low

Increasing Trend in Non-Core Income

Near 52 Week Low

Stocks Underperforming their Industry Price Change in the Quarter

Street Favorite: High Analyst Rating with at least 20% upside

Highest FII stock holdings

FII / FPI or Institutions increasing their shareholding

MFs increased their shareholding last quarter

Mutual Funds Increased Shareholding over the Past Two Months

US FDA Warning Letter

Expensive Performers (DVM)

Decline in Net Profit with falling Profit Margin (QoQ)